Identification and characterization of Poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages

Molecular Pharmacology

Volumn 83, Issue 1, 2013, Pages 61-72

  Cui, Wen Yan ^a,b,d   Zhao, Shufang ^c   Polanowska Grabowska, Renata ^f   Wang, Ju ^d   Wei, Jinxue ^d   Dash, Bhagirathi ^d   Chang, Sulie L ^e   Saucerman, Jeffrey J ^f   Gu, Jun ^b   Li, Ming D ^a,d  

^a ZHEJIANG UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d UNIVERSITY OF VIRGINIA   (United States)

^e SETON HALL UNIVERSITY   (United States)

^f University of Virginia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CALCIUM CHANNEL; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NICOTINE; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL STIMULATION; DOWNSTREAM PROCESSING; GENE EXPRESSION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS INFECTION;

ANIMALS; BUNGAROTOXINS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL LINE; DEAD-BOX RNA HELICASES; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; INTERLEUKIN-6; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NICOTINE; PHOSPHORYLATION; POLY I-C; RECEPTORS, NICOTINIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES;

EID: 84871567505     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.081497     Document Type: Article

References (69)

1. Arcavi L and Benowitz NL (2004) Cigarette smoking and infection. Arch Intern Med 164:2206-2216. (Pubitemid 39452980)
2. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, and Grando SA (2006) Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J 20:2093-2101. (Pubitemid 44953908)
3. Berridge MJ, Lipp P, and Bootman MD (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1:11-21.
4. Bertrand D, Galzi JL, Devillers-Thiéry A, Bertrand S, and Changeux JP (1993) Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc Natl Acad Sci USA 90:6971-6975. (Pubitemid 23222370)
5. Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430:257-263.
6. Blanchet MR, Israël-Assayag E, Daleau P, Beaulieu MJ, and Cormier Y (2006) Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. Am J Physiol Lung Cell Mol Physiol 291:L757-L763.
7. Blumenthal EM, Conroy WG, Romano SJ, Kassner PD, and Berg DK (1997) Detection of functional nicotinic receptors blocked by alpha-bungarotoxin on PC12 cells and dependence of their expression on post-translational events. J Neurosci 17:6094-6104. (Pubitemid 27329885)
8. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, and Tracey KJ (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-462. (Pubitemid 30367422)
9. Cao J, Dwyer JB, Mangold JE, Wang J, Wei J, Leslie FM, and Li MD (2011) Modulation of cell adhesion systems by prenatal nicotine exposure in limbic brain regions of adolescent female rats. Int J Neuropsychopharmacol 14:157-174.
10. Cheng PY, Lee YM, Law KK, Lin CW, and Yen MH (2007) The involvement of AMP-activated protein kinases in the anti-inflammatory effect of nicotine in vivo and in vitro. Biochem Pharmacol 74:1758-1765.
11. Cohen S, Tyrrell DA, Russell MA, Jarvis MJ, and Smith AP (1993) Smoking, alcohol consumption, and susceptibility to the common cold. Am J Public Health 83:1277-1283. (Pubitemid 23262033)
12. Cui WY and Li MD (2010) Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor. J Neuroimmune Pharmacol 5:479-488.
13. Cui WY, Wang J, Wei J, Cao J, Chang SL, Gu J, and Li MD (2012) Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells. Amino Acids 43:1157-1169.
14. de Bouteiller O, Merck E, Hasan UA, Hubac S, Benguigui B, Trinchieri G, Bates EE, and Caux C (2005) Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 280:38133-38145. (Pubitemid 43853708)
15. de Jonge WJ, van der Zanden EP, and The FO et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6:844-851. (Pubitemid 43090471)
16. Denda A, Endoh T, Tang Q, Tsujiuchi T, Nakae D, and Konishi Y (1998) Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats. Mutat Res 402:279-288. (Pubitemid 28440284)
17. Friedman H (1996) Drugs of abuse as possible co-factors in AIDS progression: summary of panel discussion. Adv Exp Med Biol 402:225-228.
18. Geng Y, Savage SM, Razani-Boroujerdi S, and Sopori ML (1996) Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol 156:2384-2390. (Pubitemid 26091561)
19. Guslandi M (1999) Long-term effects of a single course of nicotine treatment in acute ulcerative colitis: remission maintenance in a 12-month follow-up study. Int J Colorectal Dis 14:261-262.
20. Hamano R, Takahashi HK, Iwagaki H, Yoshino T, Nishibori M, and Tanaka N (2006) Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 26:358-364. (Pubitemid 44402020)
21. Hao J, Simard AR, Turner GH, Wu J, Whiteaker P, Lukas RJ, and Shi FD (2011) Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors. Exp Neurol 227:110-119.
22. Kark JD and Lebiush M (1981) Smoking and epidemic influenza-like illness in female military recruits: a brief survey. Am J Public Health 71:530-532. (Pubitemid 11156476)
23. Kark JD, Lebiush M, and Rannon L (1982) Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N Engl J Med 307:1042-1046. (Pubitemid 12027060)
24. Khakh BS, Fisher JA, Nashmi R, Bowser DN, and Lester HA (2005) An angstrom scale interaction between plasma membrane ATP-gated P2X2 and alpha4beta2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. J Neurosci 25:691-6920.
25. Khakh BS, Zhou X, Sydes J, Galligan JJ, and Lester HA (2000) State-dependent cross-inhibition between transmitter-gated cation channels. Nature 406:405-410. (Pubitemid 30625559)
26. Kox M, Pompe JC, Gordinou de Gouberville MC, van der Hoeven JG, Hoedemaekers CW, and Pickkers P (2011) Effects of the α7 nicotinic acetylcholine receptor agonist GTS-21 on the innate immune response in humans. Shock 36:5-11.
27. Kox M, van Velzen JF, Pompe JC, Hoedemaekers CW, van der Hoeven JG, and Pickkers P (2009) GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol 78:863-872.
28. Kumar H, Kawai T, and Kato H et al. (2006) Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203:1795-1803. (Pubitemid 44036284)
29. Kuryatov A, Luo J, Cooper J, and Lindstrom J (2005) Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors. Mol Pharmacol 68:1839-1851. (Pubitemid 41654365)
30. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, and Si-Tahar M (2007) Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178:3368-3372. (Pubitemid 46417600)
31. Lester HA, Xiao C, Srinivasan R, Son CD, Miwa J, Pantoja R, Banghart MR, Dougherty DA, Goate AM, and Wang JC (2009) Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J 11:167-177.
32. Lifson AR and Lando HA (2012) Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies. Curr HIV/AIDS Rep 9 :223-220.
33. Liu X, Yao M, Li N, Wang C, Zheng Y, and Cao X (2008) CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112:4961-4970.
34. Matri S, Karoui S, and Filali A (2000) [Tobacco and inflammatory bowel disease]. Tunis Med 78:693-698.
35. Matsunaga K, Klein TW, Friedman H, and Yamamoto Y (2001) Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 167:6518-6524. (Pubitemid 33081587)
36. Mikulski Z, Hartmann P, and Jositsch G et al. (2010) Nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration. Respir Res 11:133.
37. Mills CM, Hill SA, and Marks R (1997) Transdermal nicotine suppresses cutaneous inflammation. Arch Dermatol 133:823-825. (Pubitemid 27337540)
38. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, and Seya T (2003) TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 278:49751-49762. (Pubitemid 37548808)
39. Park SY, Baik YH, Cho JH, Kim S, Lee KS, and Han JS (2008) Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells. Cytokine 44:126-134.
40. Pavlov VA, Wang H, Czura CJ, Friedman SG, and Tracey KJ (2003) The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 9:125-134. (Pubitemid 37310949)
41. Peña VB, Bonini IC, Antollini SS, Kobayashi T, and Barrantes FJ (2011) alpha 7-type acetylcholine receptor localization and its modulation by nicotine and cholesterol in vascular endothelial cells. J Cell Biochem 112:3276-3288.
42. Prasse A, Stahl M, and Schulz G et al. (2009) Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 174:1683-1691.
43. Rakhilin S, Drisdel RC, Sagher D, McGehee DS, Vallejo Y, and Green WN (1999) alpha-Bungarotoxin receptors contain alpha7 subunits in two different disulfide-bonded conformations. J Cell Biol 146: 203-218.
44. Ranjith-Kumar CT, Miller W, and Xiong J et al. (2007) Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J Biol Chem 282:7668-7678. (Pubitemid 47093703)
45. 2+ response. J Immunol 179:2889-2898.
46. Razani-Boroujerdi S, Singh SP, Knall C, Hahn FF, Peña-Philippides JC, Kalra R, Langley RJ, and Sopori ML (2004) Chronic nicotine inhibits inflammation and promotes influenza infection. Cell Immunol 230:1-9. (Pubitemid 39482356)
47. Rosas-Ballina M, Goldstein RS, Gallowitsch-Puerta M, Yang L, Valdés-Ferrer SI, Patel NB, Chavan S, Al-Abed Y, Yang H, and Tracey KJ (2009) The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 15:195-202.
48. Sato KZ, Fujii T, Watanabe Y, Yamada S, Ando T, Kazuko F, and Kawashima K (1999) Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266:17-20. (Pubitemid 29219745)
49. Sharma G and Vijayaraghavan S (2001) Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proc Natl Acad Sci USA 98:4148-4153. (Pubitemid 32249913)
50. Shen JX and Yakel JL (2009) Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol Sin 30:673-680.
51. Shoop RD, Chang KT, Ellisman MH, and Berg DK (2001) Synaptically driven calcium transients via nicotinic receptors on somatic spines. J Neurosci 21:771-781. (Pubitemid 32163118)
52. Slack JL, Schooley K, Bonnert TP, Mitcham JL, Qwarnstrom EE, Sims JE, and Dower SK (2000) Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J Biol Chem 275:4670-4678. (Pubitemid 30108853)
53. Sopori M (2002) Effects of cigarette smoke on the immune system. Nat Rev Immunol 2:372-377.
54. Sopori ML, Kozak W, Savage SM, Geng Y, and Kluger MJ (1998) Nicotine-induced modulation of T Cell function. Implications for inflammation and infection. Adv Exp Med Biol 437:279-289.
55. Srinivasan R, Pantoja R, Moss FJ, Mackey ED, Son CD, Miwa J, and Lester HA (2011) Nicotine up-regulates alpha4beta2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning. J Gen Physiol 137:59-79.
56. Srinivasan R, Richards CI, Xiao C, Rhee D, Pantoja R, Dougherty DA, Miwa JM, and Lester HA (2012) Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response. Mol Pharmacol 81:759-769.
57. Sugano N, Shimada K, Ito K, and Murai S (1998) Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation. Biochem Biophys Res Commun 252:25-28. (Pubitemid 28534621)
58. 2+. FASEB J 25:2563-2573.
59. Tracey KJ (2002) The inflammatory reflex. Nature 420:853-859.
60. Tracey KJ and Abraham E (1999) From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies? Shock 11:224-225.
61. Tsoyi K, Jang HJ, and Kim JW et al. (2011) Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction. Antioxid Redox Signal 14:2057-2070.
62. Vijayaraghavan S, Pugh PC, Zhang ZW, Rathouz MM, and Berg DK (1992) Nicotinic receptors that bind alpha-bungarotoxin on neurons raise intracellular free Ca2+. Neuron 8:353-362.
63. Wang H, Liao H, and Ochani M et al. (2004) Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10:1216-1221. (Pubitemid 39540438)
64. Wang H, Yu M, and Ochani M et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384-388. (Pubitemid 36157937)
65. Wei J, Wang J, Dwyer JB, Mangold J, Cao J, Leslie FM, and Li MD (2011) Gestational nicotine treatment modulates cell death/survival-related pathways in the brains of adolescent female rats. Int J Neuropsychopharmacol 14:91-106.
66. Winer J, Jung CK, Shackel I, and Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49. (Pubitemid 29230718)
67. Wittebole X, Castanares-Zapatero D, and Laterre PF (2010) Toll-like receptor 4 modulation as a strategy to treat sepsis. Mediators Inflamm 2010:568396.
68. Xiao C, Nashmi R, McKinney S, Cai H, McIntosh JM, and Lester HA (2009) Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. J Neurosci 29:12428-12439.
69. Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, Kamochi H, and Suzuki N (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116-123. (Pubitemid 44393846)